DOI: 10.1055/s-00000054

Pharmacopsychiatry

eFirst

Publikationsdatum: 15 April 2024

Original Paper

Llorca-Bofí, Vicent; Bioque, Miquel; Madero, Santiago; Mallorquí, Andrea; Oliveira, Cristina; Garriga, Marina; Parellada, Eduard; García-Rizo, Clemente: Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder

Publikationsdatum: 26 März 2024

Original Paper

Takahashi, Yuna; Yatomi, Taisuke; Yamaguchi, Naohito; Yoshimura, Kimio; Hori, Satoko; Uchida, Hiroyuki: Comparable Psychotropic Prescription Rates After Hospital Discharge Between Patients with COVID-19 and Those With Non-COVID-19-Related Respiratory Infection
Supplementary Material

Publikationsdatum: 12 März 2024

Original Paper

Szejko, Natalia; Becher, Eva; Heimann, Florian; Grotenhermen, Franjo; Müller-Vahl, Kirsten R.: Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany
Supplementary Material

Publikationsdatum: 11 März 2024

Original Paper

Das, Ankita; Hendershot, Christian S.; Husain, M.Ishrat; Knyahnytska, Yuliya; Elsaid, Sonja; Le Foll, Bernard; Kloiber, Stefan: Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada – A Qualitative Study

Publikationsdatum: 06 März 2024

Review

Broers, Barbara; Bianchi, Federica: Cannabinoids for Behavioral Symptoms in Dementia: An Overview

Publikationsdatum: 01 März 2024

Review

Müller-Vahl, Kirsten R.: Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature

Publikationsdatum: 24 Januar 2024

Review

Dammann, Inga; Rohleder, Cathrin; Leweke, F. Markus: Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review

Publikationsdatum: 10 Januar 2024

Review

Karst, Matthias: Overview: Chronic Pain and Cannabis-Based Medicines